Antimicrobial Resistance in Diverse Escherichia coli Pathotypes from Nigeria.

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES
Kenneth Nnamdi Anueyiagu, Chibuzor Gerald Agu, Uzal Umar, Bruno Silvester Lopes
{"title":"Antimicrobial Resistance in Diverse <i>Escherichia coli</i> Pathotypes from Nigeria.","authors":"Kenneth Nnamdi Anueyiagu, Chibuzor Gerald Agu, Uzal Umar, Bruno Silvester Lopes","doi":"10.3390/antibiotics13100922","DOIUrl":null,"url":null,"abstract":"<p><p><i>Escherichia coli</i> is a gram-negative commensal bacterium living in human and animal intestines. Its pathogenic strains lead to high morbidity and mortality, which can adversely affect people by causing urinary tract infections, food poisoning, septic shock, or meningitis. Humans can contract <i>E. coli</i> by eating contaminated food-such as raw or undercooked raw milk, meat products, and fresh produce sold in open markets-as well as by coming into contact with contaminated settings like wastewater, municipal water, soil, and faeces. Some pathogenic strains identified in Nigeria, include Enterohemorrhagic (Verotoxigenic), Enterotoxigenic, Enteropathogenic, Enteroinvasive, and Enteroaggregative <i>E. coli</i>. This causes acute watery or bloody diarrhoea, stomach cramps, and vomiting. Apart from the virulence profile of <i>E. coli</i>, antibiotic resistance mechanisms such as the presence of <i>bla</i><sub>CTX-M</sub> found in humans, animals, and environmental isolates are of great importance and require surveillance and monitoring for emerging threats in resource-limited countries. This review is aimed at understanding the underlying mechanisms of evolution and antibiotic resistance in <i>E. coli</i> in Nigeria and highlights the use of improving One Health approaches to combat the problem of emerging infectious diseases.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504273/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics13100922","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Escherichia coli is a gram-negative commensal bacterium living in human and animal intestines. Its pathogenic strains lead to high morbidity and mortality, which can adversely affect people by causing urinary tract infections, food poisoning, septic shock, or meningitis. Humans can contract E. coli by eating contaminated food-such as raw or undercooked raw milk, meat products, and fresh produce sold in open markets-as well as by coming into contact with contaminated settings like wastewater, municipal water, soil, and faeces. Some pathogenic strains identified in Nigeria, include Enterohemorrhagic (Verotoxigenic), Enterotoxigenic, Enteropathogenic, Enteroinvasive, and Enteroaggregative E. coli. This causes acute watery or bloody diarrhoea, stomach cramps, and vomiting. Apart from the virulence profile of E. coli, antibiotic resistance mechanisms such as the presence of blaCTX-M found in humans, animals, and environmental isolates are of great importance and require surveillance and monitoring for emerging threats in resource-limited countries. This review is aimed at understanding the underlying mechanisms of evolution and antibiotic resistance in E. coli in Nigeria and highlights the use of improving One Health approaches to combat the problem of emerging infectious diseases.

尼日利亚多种大肠埃希菌病型的抗菌药耐药性。
大肠杆菌是一种生活在人类和动物肠道中的革兰氏阴性共生菌。其致病菌株会导致高发病率和高死亡率,可引起尿路感染、食物中毒、脓毒性休克或脑膜炎,对人类造成不利影响。人类可通过食用受污染的食物(如生的或未煮熟的生牛奶、肉制品和露天市场出售的新鲜农产品)以及接触受污染的环境(如废水、市政用水、土壤和粪便)感染大肠杆菌。在尼日利亚发现的一些致病菌株包括肠出血性(Verotoxigenic)、肠毒性、肠致病性、肠侵入性和肠聚集性大肠杆菌。这种大肠杆菌会导致急性水样或血样腹泻、胃痉挛和呕吐。除了大肠杆菌的毒力特征外,抗生素耐药机制(如在人类、动物和环境分离物中发现的 blaCTX-M)也非常重要,需要在资源有限的国家对新出现的威胁进行监测和监控。本综述旨在了解尼日利亚大肠杆菌的进化和抗生素耐药性的基本机制,并强调利用不断改进的 "一体健康 "方法来应对新出现的传染病问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antibiotics-Basel
Antibiotics-Basel Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍: Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信